Search

Lynette F. Smith

Examiner (ID: 15310)

Most Active Art Unit
1813
Art Unit(s)
1648, 1806, 1661, 1813, 1645, 1649
Total Applications
356
Issued Applications
174
Pending Applications
30
Abandoned Applications
152
Applications
StatisticsSubscription-Only

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 3425897 [patent_doc_number] => 05459238 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-10-17 [patent_title] => 'Peptide fragments of HIV' [patent_app_type] => 1 [patent_app_number] => 7/999377 [patent_app_country] => US [patent_app_date] => 1992-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2856 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/459/05459238.pdf [firstpage_image] =>[orig_patent_app_number] => 999377 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/999377 		Peptide fragments of HIV Dec 30, 1992 Issued
07/997153 CONSTRUCTION AND EXPRESSION OF SYNTHETIC GENES ENCODING ENVELOPE EPITOPES OF THE HUMAN T CELL LEUKEMIA VIRUS TYPE I Dec 21, 1992 Abandoned
07/989884 METHOD AND COMPOSITIONS FOR SUPPRESSING ALLOGRAFT REJECTION IN MAMMALS Dec 9, 1992 Abandoned
07/985949 HIV ANTIGEN Dec 3, 1992 Abandoned
07/979343 PRODUCTION OF HUMAN T-CELL LEUKEMIA (LYMPHOTROPIC) RETROVIRUS (HTLV-I) ENVELOPE PROTEIN FRAGMENTS IN BACTERIA AND USE IN SEROEPIDEMIOLOGICAL STUDIES Nov 19, 1992 Abandoned
07/979391 MOLECULARLY CLONED ACQUIRED IMMUNODEFICIENCY SYNDROME POLYPEPTIDES AND THEIR METHODS OF USE Nov 18, 1992 Abandoned
Array ( [id] => 2978536 [patent_doc_number] => 05256767 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-10-26 [patent_title] => 'Retroviral antigens' [patent_app_type] => 1 [patent_app_number] => 7/975899 [patent_app_country] => US [patent_app_date] => 1992-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4933 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/256/05256767.pdf [firstpage_image] =>[orig_patent_app_number] => 975899 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/975899 		Retroviral antigens Nov 9, 1992 Issued
Array ( [id] => 3683263 [patent_doc_number] => 05643577 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-01 [patent_title] => 'Oral vaccine comprising antigen surface-associated with red blood cells' [patent_app_type] => 1 [patent_app_number] => 7/940899 [patent_app_country] => US [patent_app_date] => 1992-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 17 [patent_no_of_words] => 2360 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/643/05643577.pdf [firstpage_image] =>[orig_patent_app_number] => 940899 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/940899 		Oral vaccine comprising antigen surface-associated with red blood cells Oct 22, 1992 Issued
Array ( [id] => 3059306 [patent_doc_number] => 05338829 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-08-16 [patent_title] => 'Peptides derived from human immunodeficiency virus-1 GP160' [patent_app_type] => 1 [patent_app_number] => 7/932078 [patent_app_country] => US [patent_app_date] => 1992-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 10991 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/338/05338829.pdf [firstpage_image] =>[orig_patent_app_number] => 932078 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/932078 		Peptides derived from human immunodeficiency virus-1 GP160 Oct 18, 1992 Issued
07/956682 PURIFIED AIDS-ASSOCIATED VIRUS Oct 4, 1992 Abandoned
07/947992 SEROREACTIVE EPITOPES ON PROTEINS OF HUMAN PAPILLOMAVIRUS (HPV) 18 Sep 20, 1992 Abandoned
07/943173 POTENTIATION OF IMMUNOGENIC RESPONSE Sep 13, 1992 Abandoned
07/943247 PRIMARY AND SECONDARY IMMUNIZATION WITH DIFFERENT PHYSIO-CHEMICAL FORMS OF ANTIGEN Sep 13, 1992 Abandoned
07/939576 COMPOSITION CONTAINING A B EPITOPE OF THE ENVELOPE GLYCOPROTEIN OF A RETROVIRUS AND A T EPITOPE OF ANOTHER DISTINCT PROTEIN OF THIS RETROVIRUS Sep 2, 1992 Abandoned
07/932787 PEPTIDES THAT INDUCE ANTIBODIES WHICH NEUTRALIZE GENETICALLY DIVERGENT HIV-1 ISOLATES Aug 28, 1992 Abandoned
07/768608 SYNTHETIC PEPTIDES FOR AN HIV-1 VACCINE Aug 23, 1992 Abandoned
Array ( [id] => 4284379 [patent_doc_number] => 06235243 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-22 [patent_title] => 'Gas sensor array for detecting individual gas constituents in a gas mixture' [patent_app_type] => 1 [patent_app_number] => 7/928443 [patent_app_country] => US [patent_app_date] => 1992-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 11 [patent_no_of_words] => 2459 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 185 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/235/06235243.pdf [firstpage_image] =>[orig_patent_app_number] => 928443 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/928443 		Gas sensor array for detecting individual gas constituents in a gas mixture Aug 11, 1992 Issued
07/928881 METHOD OF TREATING OR PREVENTING AUTOIMMUNE UVEORETINITIS IN MAMMALS Aug 3, 1992 Abandoned
07/922912 HERPESVIRUS VACCINES Jul 30, 1992 Abandoned
07/918224 METHOD FOR ENHANCING THE ASSOCIATION OF EXOGENOUS PEPTIDES WITH CLASS I MHC MOLECULES ON THE SURFACE OF ANTIGEN PRESENTING CELLS WITH BETA2- MICROGLOBULIN Jul 20, 1992 Abandoned
Menu